Linden Thomas Advisory Services LLC Increases Stock Holdings in Doximity, Inc. (NASDAQ:DOCS)

Linden Thomas Advisory Services LLC grew its stake in shares of Doximity, Inc. (NASDAQ:DOCS) by 2.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 40,758 shares of the company’s stock after buying an additional 793 shares during the period. Linden Thomas Advisory Services LLC’s holdings in Doximity were worth $1,143,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Creative Financial Designs Inc. ADV lifted its position in shares of Doximity by 16.7% during the 4th quarter. Creative Financial Designs Inc. ADV now owns 3,301 shares of the company’s stock valued at $93,000 after buying an additional 473 shares in the last quarter. CWM LLC lifted its position in shares of Doximity by 57.2% during the 3rd quarter. CWM LLC now owns 4,982 shares of the company’s stock valued at $106,000 after buying an additional 1,813 shares in the last quarter. Neo Ivy Capital Management purchased a new position in shares of Doximity during the 3rd quarter valued at about $109,000. PNC Financial Services Group Inc. lifted its position in shares of Doximity by 16.6% during the 3rd quarter. PNC Financial Services Group Inc. now owns 6,500 shares of the company’s stock valued at $138,000 after buying an additional 925 shares in the last quarter. Finally, Harel Insurance Investments & Financial Services Ltd. lifted its position in shares of Doximity by 174.5% during the 3rd quarter. Harel Insurance Investments & Financial Services Ltd. now owns 6,929 shares of the company’s stock valued at $146,000 after buying an additional 4,405 shares in the last quarter. 87.19% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Doximity

In other news, Director Kira Scherer Wampler sold 2,500 shares of Doximity stock in a transaction that occurred on Monday, April 1st. The stock was sold at an average price of $26.97, for a total value of $67,425.00. Following the completion of the transaction, the director now owns 10,258 shares in the company, valued at approximately $276,658.26. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 39.40% of the company’s stock.

Doximity Price Performance

NASDAQ:DOCS opened at $23.92 on Thursday. The company has a market cap of $4.46 billion, a price-to-earnings ratio of 36.24, a PEG ratio of 3.09 and a beta of 1.17. The stock’s 50 day simple moving average is $27.22 and its two-hundred day simple moving average is $26.19. Doximity, Inc. has a 1 year low of $19.71 and a 1 year high of $36.92.

Doximity (NASDAQ:DOCS) last announced its earnings results on Thursday, February 8th. The company reported $0.25 EPS for the quarter, topping analysts’ consensus estimates of $0.19 by $0.06. The firm had revenue of $135.28 million during the quarter, compared to analysts’ expectations of $127.46 million. Doximity had a return on equity of 16.08% and a net margin of 29.39%. As a group, analysts anticipate that Doximity, Inc. will post 0.72 EPS for the current year.

Analyst Ratings Changes

A number of research firms have recently weighed in on DOCS. Wells Fargo & Company lifted their price objective on Doximity from $25.00 to $27.00 and gave the company an “equal weight” rating in a research report on Friday, February 9th. Bank of America lifted their target price on Doximity from $29.00 to $32.00 and gave the company a “neutral” rating in a research note on Tuesday, January 23rd. Evercore ISI reissued an “in-line” rating and set a $30.00 target price on shares of Doximity in a research note on Tuesday, April 2nd. Truist Financial lifted their target price on Doximity from $28.00 to $29.00 and gave the company a “hold” rating in a research note on Friday, February 9th. Finally, Leerink Partnrs reissued a “market perform” rating on shares of Doximity in a research note on Monday, February 26th. One research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, Doximity currently has an average rating of “Hold” and an average price target of $28.82.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.